Bayer CropScience Limited (BOM:506285)
India · Delayed Price · Currency is INR 3,485.25
+89.15 (2.63%)
At close: Nov 9, 2026
Bayer CropScience Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Operating Revenue | 52,927 | 56,750 | 54,734 | 51,062 | 51,397 | 47,344 |
| 52,927 | 56,750 | 54,734 | 51,062 | 51,397 | 47,344 | |
Revenue Growth | -5.01% | 3.68% | 7.19% | -0.65% | 8.56% | 11.10% |
Cost of Revenue | 29,505 | 33,924 | 34,142 | 29,256 | 28,305 | 26,771 |
Gross Profit | 23,422 | 22,826 | 20,592 | 21,806 | 23,092 | 20,573 |
Selling, General & Admin | 7,600 | 7,585 | 7,526 | 6,902 | 8,616 | 7,836 |
Other Operating Expenses | 6,765 | 6,500 | 6,150 | 5,117 | 5,211 | 4,589 |
Operating Expenses | 15,540 | 15,025 | 14,525 | 12,759 | 14,622 | 13,070 |
Operating Income | 7,882 | 7,801 | 6,067 | 9,047 | 8,470 | 7,503 |
Interest Expense | -197 | -198 | -170 | -196 | -223 | -118 |
Interest & Investment Income | 421 | 421 | 566 | 484 | 340 | 245 |
Currency Exchange Gain (Loss) | 8 | 8 | -2 | -2 | -22 | -2 |
Other Non Operating Income (Expenses) | 840 | 142 | 166 | 148 | 159 | 184 |
EBT Excluding Unusual Items | 8,954 | 8,174 | 6,627 | 9,481 | 8,724 | 7,812 |
Gain (Loss) on Sale of Investments | 156 | 156 | 191 | 148 | 135 | 94 |
Gain (Loss) on Sale of Assets | 223 | 223 | 256 | -24 | 1,043 | 579 |
Asset Writedown | -4 | -4 | - | -191 | -1 | -17 |
Pretax Income | 9,329 | 8,549 | 7,074 | 9,414 | 9,901 | 8,468 |
Income Tax Expense | 1,873 | 1,657 | 1,394 | 2,009 | 2,319 | 2,015 |
Net Income | 7,456 | 6,892 | 5,680 | 7,405 | 7,582 | 6,453 |
Net Income to Common | 7,456 | 6,892 | 5,680 | 7,405 | 7,582 | 6,453 |
Net Income Growth | 22.45% | 21.34% | -23.29% | -2.33% | 17.50% | 30.87% |
Shares Outstanding (Basic) | 45 | 45 | 45 | 45 | 45 | 45 |
Shares Outstanding (Diluted) | 45 | 45 | 45 | 45 | 45 | 45 |
Shares Change | -0.00% | - | - | - | - | - |
EPS (Basic) | 165.90 | 153.35 | 126.38 | 164.77 | 168.71 | 143.58 |
EPS (Diluted) | 165.90 | 153.35 | 126.38 | 164.77 | 168.71 | 143.58 |
EPS Growth | 22.45% | 21.34% | -23.29% | -2.33% | 17.50% | 30.87% |
Additional Metrics
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Free Cash Flow | 4,379 | 10,386 | 2,362 | 9,059 | 5,320 | 1,601 |
Free Cash Flow Per Share | 97.44 | 231.10 | 52.56 | 201.57 | 118.38 | 35.62 |
Dividend Per Share | 150.000 | 150.000 | 125.000 | 140.000 | 130.000 | 25.000 |
Dividend Growth | 20.00% | 20.00% | -10.71% | 7.69% | 420.00% | -78.26% |
Gross Margin | 44.25% | 40.22% | 37.62% | 42.70% | 44.93% | 43.45% |
Operating Margin | 14.89% | 13.75% | 11.09% | 17.72% | 16.48% | 15.85% |
Profit Margin | 14.09% | 12.14% | 10.38% | 14.50% | 14.75% | 13.63% |
Free Cash Flow Margin | 8.27% | 18.30% | 4.32% | 17.74% | 10.35% | 3.38% |
EBITDA | 8,495 | 8,179 | 6,429 | 9,434 | 8,861 | 7,901 |
EBITDA Margin | 16.05% | 14.41% | 11.75% | 18.48% | 17.24% | 16.69% |
D&A For EBITDA | 613 | 378 | 362 | 387 | 391 | 398 |
EBIT | 7,882 | 7,801 | 6,067 | 9,047 | 8,470 | 7,503 |
EBIT Margin | 14.89% | 13.75% | 11.09% | 17.72% | 16.48% | 15.85% |
Effective Tax Rate | 20.08% | 19.38% | 19.71% | 21.34% | 23.42% | 23.79% |
Revenue as Reported | 54,575 | 57,700 | 55,931 | 51,842 | 52,036 | 47,890 |
Advertising Expenses | - | 3,098 | 2,926 | 2,412 | 3,153 | 3,080 |